Cited 0 times in Scipus Cited Count

Clinical feasibility of deep learning-based auto-segmentation of target volumes and organs-at-risk in breast cancer patients after breast-conserving surgery

DC Field Value Language
dc.contributor.authorChung, SY-
dc.contributor.authorChang, JS-
dc.contributor.authorChoi, MS-
dc.contributor.authorChang, Y-
dc.contributor.authorChoi, BS-
dc.contributor.authorChun, J-
dc.contributor.authorKeum, KC-
dc.contributor.authorKim, JS-
dc.contributor.authorKim, YB-
dc.date.accessioned2023-01-26T06:10:26Z-
dc.date.available2023-01-26T06:10:26Z-
dc.date.issued2021-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/24092-
dc.description.abstractBackground: In breast cancer patients receiving radiotherapy (RT), accurate target delineation and reduction of radiation doses to the nearby normal organs is important. However, manual clinical target volume (CTV) and organs-at-risk (OARs) segmentation for treatment planning increases physicians’ workload and inter-physician variability considerably. In this study, we evaluated the potential benefits of deep learning-based auto-segmented contours by comparing them to manually delineated contours for breast cancer patients. Methods: CTVs for bilateral breasts, regional lymph nodes, and OARs (including the heart, lungs, esophagus, spinal cord, and thyroid) were manually delineated on planning computed tomography scans of 111 breast cancer patients who received breast-conserving surgery. Subsequently, a two-stage convolutional neural network algorithm was used. Quantitative metrics, including the Dice similarity coefficient (DSC) and 95% Hausdorff distance, and qualitative scoring by two panels from 10 institutions were used for analysis. Inter-observer variability and delineation time were assessed; furthermore, dose-volume histograms and dosimetric parameters were also analyzed using another set of patient data. Results: The correlation between the auto-segmented and manual contours was acceptable for OARs, with a mean DSC higher than 0.80 for all OARs. In addition, the CTVs showed favorable results, with mean DSCs higher than 0.70 for all breast and regional lymph node CTVs. Furthermore, qualitative subjective scoring showed that the results were acceptable for all CTVs and OARs, with a median score of at least 8 (possible range: 0–10) for (1) the differences between manual and auto-segmented contours and (2) the extent to which auto-segmentation would assist physicians in clinical practice. The differences in dosimetric parameters between the auto-segmented and manual contours were minimal. Conclusions: The feasibility of deep learning-based auto-segmentation in breast RT planning was demonstrated. Although deep learning-based auto-segmentation cannot be a substitute for radiation oncologists, it is a useful tool with excellent potential in assisting radiation oncologists in the future. Trial registration Retrospectively registered.-
dc.language.isoen-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHBreast Neoplasms-
dc.subject.MESHDeep Learning-
dc.subject.MESHFeasibility Studies-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHMastectomy, Segmental-
dc.subject.MESHMiddle Aged-
dc.subject.MESHObserver Variation-
dc.subject.MESHOrgans at Risk-
dc.subject.MESHRadiometry-
dc.subject.MESHRadiotherapy Planning, Computer-Assisted-
dc.subject.MESHRadiotherapy, Intensity-Modulated-
dc.subject.MESHTomography, X-Ray Computed-
dc.titleClinical feasibility of deep learning-based auto-segmentation of target volumes and organs-at-risk in breast cancer patients after breast-conserving surgery-
dc.typeArticle-
dc.identifier.pmid33632248-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905884/-
dc.subject.keywordAuto-segmentation-
dc.subject.keywordBreast cancer-
dc.subject.keywordClinical target volume-
dc.subject.keywordDeep learning-
dc.subject.keywordOrgans-at-risk-
dc.contributor.affiliatedAuthorChung, SY-
dc.type.localJournal Papers-
dc.identifier.doi10.1186/s13014-021-01771-z-
dc.citation.titleRadiation oncology (London, England)-
dc.citation.volume16-
dc.citation.number1-
dc.citation.date2021-
dc.citation.startPage44-
dc.citation.endPage44-
dc.identifier.bibliographicCitationRadiation oncology (London, England), 16(1). : 44-44, 2021-
dc.identifier.eissn1748-717X-
dc.relation.journalidJ01748717X-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Radiation Oncology
Files in This Item:
33632248.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse